Recap: Clovis Oncology Q2 Earnings

Recap: Clovis Oncology Q2 Earnings


Clovis Oncology CLVS reported its Q2 earnings results on Monday, August 8, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.


Clovis Oncology missed estimated earnings by 21.95%, reporting an EPS of $-0.5 versus an estimate of $-0.41.

Revenue was down $4.68 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 12.5% drop in the share price the next day.

Here's a look at Clovis Oncology's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.43 -0.56 -0.48 -0.56
EPS Actual -0.44 -0.48 -0.56 -0.59
Revenue Estimate 36.97M 39.08M 39.09M 41.12M
Revenue Actual 34.25M 35.97M 37.92M 36.82M

To track all earnings releases for Clovis Oncology visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarningsNews